Development of a high throughput, semi-automated, infectious center cell-based ELISA for equine infectious anemia virus

Journal of Virological Methods

Volumn 185, Issue 2, 2012, Pages 221-227

  Craigo, Jodi K ^a,b   Ezzelarab, Corin ^a   Montelaro, Ronald C ^a,b  

^a UNIVERSITY OF PITTSBURGH   (United States)

^b UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

Author keywords

Infectious center assay; Neutralization; Viral titer

Indexed keywords

VIRUS PROTEIN;

ARTICLE; ASSAY; AUTOMATION; COLORIMETRY; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; EQUINE INFECTIOUS ANEMIA VIRUS; HORSE; INFECTIOUS CENTER ASSAY; NONHUMAN; PRIORITY JOURNAL; PROCESS OPTIMIZATION; REACTION TIME; SENSITIVITY AND SPECIFICITY; VIRUS INFECTIVITY; VIRUS NEUTRALIZATION; VIRUS TITER ASSAY;

ANIMALS; ANTIBODIES, NEUTRALIZING; ANTIBODIES, VIRAL; AUTOMATION, LABORATORY; CELL LINE; ENZYME-LINKED IMMUNOSORBENT ASSAY; HIGH-THROUGHPUT SCREENING ASSAYS; INDICATORS AND REAGENTS; INFECTIOUS ANEMIA VIRUS, EQUINE; NEUTRALIZATION TESTS; SENSITIVITY AND SPECIFICITY; TIME FACTORS; VIRAL PLAQUE ASSAY; VIRAL PROTEINS;

EID: 84867609456     PISSN: 01660934     EISSN: 18790984     Source Type: Journal    
DOI: 10.1016/j.jviromet.2012.07.007     Document Type: Article

References (31)

1. APHIS Equine Infectious Anemia (EIA) 2006, Veternairy Services. USDA. (Ed.).
2. Carpenter S., Evans L.H., Sevoian M., Chesebro B. In vivo and in vitro selection of equine infectious anemia virus variants. Applied Virology Research II: Virus Variation, Epidemiology, and Control 1990, 99-115. Plenum Publishing, New York. E. Kurstak, R.G. Marusyk, F.A. Murphy, M.H.V. Van Regenmortel (Eds.).
3. Craigo J.K., Barnes S., Cook S.J., Issel C.J., Montelaro R.C. Divergence, not diversity of an attenuated equine lentivirus vaccine strain correlates with protection from disease. Vaccine 2010, 28:8095-8104.
4. Craigo J.K., Barnes S., Zhang B., Cook S.J., Howe L., Issel C.J., Montelaro R.C. An EIAV field isolate reveals much higher levels of subtype variability than currently reported for the equine lentivirus family. Retrovirology 2009, 6:95.
5. Craigo J.K., Durkin S., Sturgeon T.J., Tagmyer T., Cook S.J., Issel C.J., Montelaro R.C. Immune suppression of challenged vaccinates as a rigorous assessment of sterile protection by lentiviral vaccines. Vaccine 2007, 25:834-845.
6. Craigo J.K., Leroux C., Howe L., Steckbeck J.D., Cook S.J., Issel C.J., Montelaro R.C. Transient immune suppression of inapparent carriers infected with a principal neutralizing domain-deficient equine infectious anaemia virus induces neutralizing antibodies and lowers steady-state virus replication. Journal of General Virology 2002, 83:1353-1359.
7. Craigo J.K., Li F., Steckbeck J.D., Durkin S., Howe L., Cook S.J., Issel C.J., Montelaro R.C. Discerning an effective balance between equine infectious anemia virus attenuation and vaccine efficacy. Journal of Virology 2005, 79:2666-2677.
8. Craigo J.K., Montelaro R.C. Equine Infectious Anemia Virus (Retroviridae), Encyclopedia of Virology 2008, vol. 3. Elsevier, Oxford, 167-174.
9. Craigo J.K., Sturgeon T.J., Cook S.J., Issel C.J., Leroux C., Montelaro R.C. Apparent elimination of EIAV ancestral species in a long-term inapparent carrier. Virology 2006, 344:340-353.
10. Craigo J.K., Zhang B., Barnes S., Tagmyer T.L., Cook S.J., Issel C.J., Montelaro R.C. Envelope variation as a primary determinant of lentiviral vaccine efficacy. Proceedings of the National Academy of Sciences of the United States of America 2007, 104:15105-15110.
11. Grund C.H., Lechman E.R., Issel C.J., Montelaro R.C., Rushlow K.E. Lentivirus cross-reactive determinants present in the capsid protein of equine infectious anaemia virus. The Journal of General Virology 1994, 75(Pt 3):657-662.
12. Grund C.H., Lechman E.R., Pezzuolo N.A., Issel C.J., Montelaro R.C. Fine specificity of equine infectious anaemia virus gp90-specific antibodies associated with protective and enhancing immune responses in experimentally infected and immunized ponies. The Journal of General Virology 1996, 77(Pt 3):435-442.
13. Hammond S.A., Cook S.J., Lichtenstein D.L., Issel C.J., Montelaro R.C. Maturation of the cellular and humoral immune responses to persistent infection in horses by equine infectious anemia virus is a complex and lengthy process. Journal of Virology 1997, 71:3840-3852.
14. Hammond S.A., Li F., McKeon B.M., Cook S.J., Issel C.J., Montelaro R.C. Immune responses and viral replication in long-term inapparent carrier ponies inoculated with equine infectious anemia virus. Journal of Virology 2000, 74:5968-5981.
15. Hammond S.A., Raabe M.L., Issel C.J., Montelaro R.C. Evaluation of antibody parameters as potential correlates of protection or enhancement by experimental vaccines to equine infectious anemia virus. Virology 1999, 262:416-430.
16. Harrold S.M., Cook S.J., Cook R.F., Rushlow K.E., Issel C.J., Montelaro R.C. Tissue sites of persistent infection and active replication of equine infectious anemia virus during acute disease and asymptomatic infection in experimentally infected equids. Journal of Virology 2000, 74:3112-3121.
17. Howe L., Craigo J.K., Issel C.J., Montelaro R.C. Specificity of serum neutralizing antibodies induced by transient immune suppression of inapparent carrier ponies infected with a neutralization-resistant equine infectious anemia virus envelope strain. Journal of General Virology 2005, 86:139-149.
18. Howe L., Leroux C., Issel C.J., Montelaro R.C. Equine infectious anemia virus envelope evolution in vivo during persistent infection progressively increases resistance to in vitro serum antibody neutralization as a dominant phenotype. Journal of Virology 2002, 76:10588.
19. Issel C.J., Foil L.D. Studies on equine infectious anemia virus transmission by insects. Journal of the American Veterinary Medical Association 1984, 184:293-297.
20. Jiang C.G., Gao X., Ma J., Lin Y.Z., Wang X.F., Zhao L.P., Hua Y.P., Liu D., Zhou J.H. C-terminal truncation of the transmembrane protein of an attenuated lentiviral vaccine alters its in vitro but not in vivo replication and weakens its potential pathogenicity. Virus Research 2011, 158:235-245.
21. Kono Y., Hirasawa K., Fukunaga Y., Taniguchi T. Recrudesence of equine infectious anemia by treatment with immunosuppressive drugs. National Institute of Animal Health Quarterly 1976, 16:8-15.
22. Leroux C., Cadore J.L., Montelaro R.C. Equine infectious anemia virus (EIAV): what has HIV's country cousin got to tell us?. Veterinary Research 2004, 35:485-512.
23. Leroux C., Issel C.J., Montelaro R.C. Novel and dynamic evolution of equine infectious anemia virus genomic quasispecies associated with sequential disease cycles in an experimentally infected pony. Journal of Virology 1997, 71:9627-9639.
24. Li F., Leroux C., Craigo J.K., Cook S.J., Issel C.J., Montelaro R.C. The S2 gene of equine infectious anemia virus is a highly conserved determinant of viral replication and virulence properties in experimentally infected ponies. Journal of Virology 2000, 74:573-579.
25. Mascola J.R., D'Souza P., Gilbert P., Hahn B.H., Haigwood N.L., Morris L., Petropoulos C.J., Polonis V.R., Sarzotti M., Montefiori D.C. Recommendations for the design and use of standard virus panels to assess neutralizing antibody responses elicited by candidate human immunodeficiency virus type 1 vaccines. Journal of Virology 2005, 79:10103-10107.
26. Montelaro R.C., Ball J.M., Rushlow K. Equine retroviruses. The Retroviridae 1993, vol. 2:257-360. Plenum Press, New York, NY.
27. Payne S.L., Rushlow K., Dhruva B.R., Issel C.J., Montelaro R.C. Localization of conserved and variable antigenic domains of equine infectious anemia virus envelope glycoproteins using recombinant env-encoded protein fragments produced in Escherichia coli. Virology 1989, 172:609-615.
28. Rwambo P.M., Issel C.J., Hussain K.A., Montelaro R.C. In vitro isolation of a neutralization escape mutant of equine infectious anemia virus (EIAV). Archives of Virology 1990, 111:275-280.
29. Sponseller B.A., Sparks W.O., Wannemuehler Y., Li Y., Antons A.K., Oaks J.L., Carpenter S. Immune selection of equine infectious anemia virus env variants during the long-term inapparent stage of disease. Virology 2007, 363:156-165.
30. Zheng Y.H., Nakaya T., Sentsui H., Kameoka M., Kishi M., Hagiwara K., Takahashi H., Kono Y., Ikuta K. Insertions, duplications and substitutions in restricted gp90 regions of equine infectious anemia virus during febrile episodes in an experimentally infected horse. Journal of General Virology 1997, 78:807-820.
31. Zheng Y.H., Sentsui H., Nakaya T., Kono Y., Ikuta K. In vivo dynamics of equine infectious anemia viruses emerging during febrile episodes: insertions/duplications at the principal neutralizing domain. Journal of Virology 1997, 71:5031-5039.